Table 1.

Interaction of VRC and TRB against 39 paired and serialC. albicans isolates from HIV-infected patients with OPC

Patient no.IsolateMIC (μg/ml) of the following drugs:ΣFIC index for TRB-VRCInterpretationa
FLCTRBVRCTRB-VRC
1mb4389>64>8>160.25/0.030.03Syn
mb6860>648160.25/0.0150.03Syn
mb1307>644160.25/0.0150.06Syn
mb8808>648160.25/0.030.03Syn
mb8456>64840.25/0.1250.06Syn
mb454432814.0/0.51.00In
mb857732>814.0/0.51.00In
2mb2771220.0150.125/≤0.0070.53In
mb858621≤0.007≤0.06/≤0.0071.06In
mb6935820.060.5/≤0.0070.37Syn
mb4657820.060.5/≤0.0070.37Syn
mb2421>6410.250.5/0.1251.00In
3mb1873880.25≤0.06/0.251.01In
mb55503280.50.5/0.250.56In
4mb167224160.125/0.0150.03Syn
mb8781>64840.25/0.060.05Syn
mb5330>648160.125/0.250.03Syn
5mb40740.520.06≤0.06/0.0150.25Syn
mb74080220.0150.5/≤0.0070.72In
6mb1447220.06≤0.06/0.061.03In
mb2771420.125≤0.06/0.060.51In
mb7040840.1250.25/0.030.49Syn
7mb93291680.252/0.1250.75In
mb8292>6480.52/0.250.75In
8mb21430.520.25≤0.06/≤0.0070.06Syn
mb482122≤0.007≤0.06/≤0.0071.03In
9mb42561680.52/0.060.37Syn
mb396164810.5/0.250.32Syn
10mb47381610.1250.25/0.0150.37Syn
mb56451640.1250.25/0.0150.18Syn
mb4753120.030.25/≤0.0070.36Syn
11B30.51≤0.007≤0.06/≤0.0071.06In
B43280.1252/0.0150.37Syn
12F2810.030.25/≤0.0070.48Syn
F5>6480.251/0.030.25Syn
13G20.520.015≤0.06/≤0.0070.50Syn
G5>6440.1250.5/0.060.61In
14Gu4420.030.5/≤0.0070.48Syn
Gu5>64>810.125/0.50.52In
Control strains86210.520.03≤0.06/≤0.0070.26Syn
230≤0.12520.030.125/≤0.0070.36Syn
  • a Syn, synergistic; In, indifferent.